Posts

AstraZeneca Pays $1.2B Upfront in $18.5B Deal for CSPC's Long-Acting Obesity Drugs

on

Sanofi Discontinues mRNA Seasonal Flu Vaccine Development, Focuses on Existing Vaccines Amid CEO Confidence

on

Lilly Invests $85M Upfront in Repertoire Immune Medicines for Autoimmune Therapies Partnership

on

AstraZeneca Announces $15 Billion Investment in China Through 2030

on

TECregen Appoints Dr. Klaas P. Zuideveld as CEO to Lead Thymus Regeneration Platform

on

Friday Five: Sanofi and Roche Face Headwinds Amid US Pricing Pressures and 2026 Drug Pipeline Shifts

on

Luma Health Welcomes Michael Chou as SVP of Product to Accelerate Operational AI Development

on

The Lancet Publishes TRICORDER Study: AI-Enabled Stethoscopes Boost Cardiac Detection in NHS Trial

on

Reperio Health and Amazon One Medical Partner to Streamline At-Home Preventive Care

on

Biotech's New Cycle, JPM 2026 Deal Hype, and Hidden Alpha Opportunities

on

Vera Therapeutics Appoints Matt Skelton as Chief Commercial Officer

on

IRA Medicare Drug Price Negotiation: Round Three Expected in 2028 with Reforms Aimed at Pharma Manageability

on

Eikon and Veradermics Announce IPO Targets Amid Biotech Market Optimism

on

HHS Issues Guidance to Shield Pharma from Anti-Kickback Violations in TrumpRx Direct-to-Consumer Drug Sales

on

Formation Bio Eyes Abivax-Like Success with Chinese Drug Licensing Deal Targeting Same Mechanism

on

Convergent Therapeutics Appoints Elizabeth L. Montgomery as Chief People Officer

on

Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors

on

Unravel Biosciences and The SCN2A Foundation Announce Drug Discovery Collaboration

on

Seno Medical's Next-Generation Imagio Imaging System Receives EU MDR CE Mark Certification

on

FDA Lifts Clinical Hold on Intellia's MAGNITUDE-2 Phase 3 Trial for Nex-Z in ATTRv-PN

on

Spotlight On: AI in Genomics and Multimodal Data Analysis Loosens Orphan Drug R&D Bottlenecks

on

FDA Places Clinical Holds on Regenxbio's RGX-111 and RGX-121 Gene Therapy Trials After Brain Tumor in Patient

on

Surge in Investments Driving Genetic and Pharma Innovations in 2026

on

Biopharma Sentiment Index Q1 2026: Positive Outlook Amid Rally and Challenges

on

Cardiff Oncology Stock Craters Amid Executive Exits and Mixed Mid-Stage Data

on

Insilico Medicine Secures Nearly $120M AI-Driven Cardiometabolic Drug Deal with Qilu Pharmaceutical

on

Boehringer Ingelheim Signs €1.05 Billion Deal for Simcere's Preclinical IBD Bispecific SIM0709

on

CMS Selects Trulicity and Biktarvy Among 15 Drugs for Third Medicare Price Negotiation Cycle

on

Boehringer Ingelheim Advances Apecotrep to Phase 3 for Rare Kidney Disease FSGS Despite Mixed Mid-Stage Data

on

Eli Lilly Partners with Seamless Therapeutics on Up to $1.12B Recombinase Gene Editing Deal for Hearing Loss

on

Qlaris Bio Appoints Robert Warner to Board of Directors

on

Zag Bio Appoints Jan Hillson, M.D., as Chief Medical Officer

on

Tempus AI's IPS Test Outperforms Conventional Biomarkers in Predicting Immunotherapy Outcomes

on

Sevaro Health Expands Leadership Team with Key Appointments

on

Premier Inc. Reports Strong Q4 FY2025 Results Exceeding Guidance Despite Segment Challenges

on

Roche's CT-388 Obesity Drug Achieves 22.5% Weight Loss in Phase II, Advances to Phase III

on

SBA Defends 8(a) Program Reforms Amid Constitutional Challenges and Increased Scrutiny in 2026

on

AsedaSciences and GenEvolutioN Announce Sales & Marketing Agreement to Integrate Genotoxicity Screen into 3RnD Platform

on

Narmafotinib Large-Scale Manufacture Complete by Amplia Therapeutics

on

Sarepta Therapeutics Reports Positive Three-Year EMBARK Data for Elevidys in Duchenne Amid Past Safety Concerns

on

QIAGEN Appoints Mark Stevenson to Supervisory Board

on

AsedaSciences and Clyde Biosciences Announce Commercial Agreement to Integrate Human-Relevant Cardiotoxicity Screening

on

Rare Disease Vouchers Caught in Political Abyss: Recent Updates on Reauthorization Efforts

on

Revolution Medicines Rejects Merck's Acquisition Bid, Stands Firm on Valuation Amid Ongoing Interest

on

Argo Biopharma Announces First Patient Dosed in Phase 2b Trial of siRNA Therapeutic BW-20829 for Elevated Lp(a)

on

Sanofi's Amlitelimab Shows Mixed Phase 3 Results in Eczema Trials, Clouds Blockbuster Hopes but Advances to Regulatory Filings

on

Novo Nordisk's Wegovy Pill Launches Strongly Amid Analyst Caution

on

Corxel Pharmaceuticals Raises $287M Series D1 to Advance Oral GLP-1 Obesity Drug CX11

on

Orphan Drug Trends: A Data-Driven Analysis

on

J&J Targets $100 Billion in 2026 Sales Despite Stelara Patent Cliff

on

Hua Medicine Advances Dorzagliatin Expansion Beyond China with Hong Kong NDA Acceptance

on

BioMarin Veterans Launch Mendra Biotech with $82M for AI-Driven Rare Disease Drugs

on

MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair

on